Biotech Distilled 133 companies · 839 active programs
Substack ↗ Subscribe

Home › Therapeutic areas › Renal

Renal (12 companies · 11 conditions)

Conditions

Immunoglobulin A Nephropathy 6 Rare Lupus Nephritis 6 Rare Focal Segmental Glomerulosclerosis 4 Rare Membranous Nephropathy 2 Rare Acute Kidney Injury 1 C3 Glomerulopathy 1 Rare Chronic Kidney Disease 1 Cystinuria 1 Rare Diabetes Insipidus 1 Rare Hyperphosphatemia 1 Minimal Change Disease 1 Rare

Companies

Ticker Company Therapeutic areas In Renal Lead stage Programs
AKBA Akebia Therapeutics, Inc. HematologyOphthalmologyRenalRespiratory Rare 7 Approved 14
ANNX Annexon, Inc. HematologyNeurologyOphthalmologyRenal Rare 1 NDA Submitted 6
ARTV Artiva Biotherapeutics, Inc. DermatologyImmunologyOncologyRenal Rare 1 Phase 2 16
CABA Cabaletta Bio, Inc. DermatologyImmunologyNeurologyRenal Rare 1 Phase 1 8
IPSC Century Therapeutics, Inc. ImmunologyMetabolicRenal Rare 2 Phase 1 11
CLYM Climb Bio, Inc. HematologyImmunologyRenal Rare 3 Phase 2 7
ETON Eton Pharmaceuticals, Inc. GI/HepatologyMetabolicRenal Rare 1 Approved 14
JBIO Jade Biosciences, Inc. ImmunologyRenal Rare 1 Phase 1 5
KYTX Kyverna Therapeutics, Inc. ImmunologyNeurologyRenal Rare 1 NDA Submitted 7
PCSA Processa Pharmaceuticals, Inc. GI/HepatologyOncologyRenal Rare 2 Phase 2 8
TVTX Travere Therapeutics, Inc. MetabolicRenal Rare 3 Approved 4
VERA Vera Therapeutics, Inc. Infectious DiseaseRenal Rare 5 NDA Submitted 8